Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $566.42M.
ENTERPRISE VALUE (EV)
$566.42M
Evolus, Inc.
Market Cap
$474.15M
Enterprise Value (EV)
$566.42M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Evolus, Inc. (EOLS) | $474.15M | $566.42M |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.59M | $255.69M |
| Arvinas, Inc. (ARVN)vs › | $476.17M | $390.07M |
| Contineum Therapeutics, Inc. (CTNM)vs › | $468.01M | $459.87M |
| Cerus Corporation (CERS)vs › | $467.54M | $526.36M |
| NRC Health (NRC)vs › | $462.45M | $549.15M |
| Kamada Ltd. (KMDA)vs › | $458.09M | $440.42M |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $454.51M | $449.56M |
| NeoGenomics, Inc. (NEO)vs › | $451.46M | $754.29M |
| Assembly Biosciences, Inc. (ASMB)vs › | $441.36M | $411.42M |
Market Cap
$474.15M
Total Debt
$146.10M
Cash
$53.83M
Enterprise Value
$566.42M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
